| Hannaford Supermarket Pharmacy 8383 | |
| 255 Joseph E. Warner Blvd, Taunton, Massachusetts 02780 | |
| (508) 824-1057 |
| Name | Hannaford Supermarket Pharmacy 8383 |
|---|---|
| Organization Name | Victory Distributors, Llc |
| Location | 255 Joseph E. Warner Blvd, Taunton, Massachusetts 02780 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (508) 824-1057 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Merck and Cardiome Pharma Corp. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended marketing approval for BRINAVESS® (vernakalant), an investigational intravenous (IV) formulation for the conversion of recent onset atrial fibrillation (AF) to sinus rhythm in adults.
The Food and Drug Administration (FDA) will hold a public hearing on June 12 and 13, 2007, to obtain feedback on FDA's Medication Guide program.
Lower awareness of COVID-19, poorer health and economic conditions could reduce the effectiveness of lockdowns in developing countries, according to researchers from The University of Western Australia.
Oncolytics Biotech Inc. today announced that SAFC, a Division of Sigma-Aldrich Corporation, has commenced validation activities designed to demonstrate the manufacturing process for the commercial production of REOLYSIN, Oncolytics' proprietary formulation of reovirus, is robust and reproducible.
› Verified 6 days ago
| NPI Number | 1245463876 |
| Organization Name | VICTORY DISTRIBUTORS, LLC |
| Doing Business As | HANNAFORD FOOD & DRUG #8383 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 255 Joseph E. Warner Blvd, Taunton, MA 02780 |
| Phone Number | 580-824-1057 |
News Archive
Merck and Cardiome Pharma Corp. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended marketing approval for BRINAVESS® (vernakalant), an investigational intravenous (IV) formulation for the conversion of recent onset atrial fibrillation (AF) to sinus rhythm in adults.
The Food and Drug Administration (FDA) will hold a public hearing on June 12 and 13, 2007, to obtain feedback on FDA's Medication Guide program.
Lower awareness of COVID-19, poorer health and economic conditions could reduce the effectiveness of lockdowns in developing countries, according to researchers from The University of Western Australia.
Oncolytics Biotech Inc. today announced that SAFC, a Division of Sigma-Aldrich Corporation, has commenced validation activities designed to demonstrate the manufacturing process for the commercial production of REOLYSIN, Oncolytics' proprietary formulation of reovirus, is robust and reproducible.
› Verified 6 days ago
| NPI Number | 1790893170 |
| Organization Name | VICTORY DISTRIBUTORS LLC |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 255 Joseph E Warner Blvd, Taunton, MA 02780 |
| Phone Number | 508-824-1057 |
News Archive
Merck and Cardiome Pharma Corp. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended marketing approval for BRINAVESS® (vernakalant), an investigational intravenous (IV) formulation for the conversion of recent onset atrial fibrillation (AF) to sinus rhythm in adults.
The Food and Drug Administration (FDA) will hold a public hearing on June 12 and 13, 2007, to obtain feedback on FDA's Medication Guide program.
Lower awareness of COVID-19, poorer health and economic conditions could reduce the effectiveness of lockdowns in developing countries, according to researchers from The University of Western Australia.
Oncolytics Biotech Inc. today announced that SAFC, a Division of Sigma-Aldrich Corporation, has commenced validation activities designed to demonstrate the manufacturing process for the commercial production of REOLYSIN, Oncolytics' proprietary formulation of reovirus, is robust and reproducible.
› Verified 6 days ago
News Archive
Merck and Cardiome Pharma Corp. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended marketing approval for BRINAVESS® (vernakalant), an investigational intravenous (IV) formulation for the conversion of recent onset atrial fibrillation (AF) to sinus rhythm in adults.
The Food and Drug Administration (FDA) will hold a public hearing on June 12 and 13, 2007, to obtain feedback on FDA's Medication Guide program.
Lower awareness of COVID-19, poorer health and economic conditions could reduce the effectiveness of lockdowns in developing countries, according to researchers from The University of Western Australia.
Oncolytics Biotech Inc. today announced that SAFC, a Division of Sigma-Aldrich Corporation, has commenced validation activities designed to demonstrate the manufacturing process for the commercial production of REOLYSIN, Oncolytics' proprietary formulation of reovirus, is robust and reproducible.
› Verified 6 days ago
Cvs Pharmacy #16547 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 81 Taunton Depot Dr, Taunton, Massachusetts 02780 Phone: (508) 824-5848 | |
Cvs Phamracy #05402 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 7 Washington St, Taunton, Massachusetts 02780 Phone: (508) 821-5605 | |
Cvs Pharmacy # 01041 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 675 County Street, Taunton, Massachusetts 02780 Phone: (508) 823-5376 | |
Walgreen #15591 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 57 Winthrop St., Taunton, Massachusetts 02780 Phone: (508) 824-5332 | |
Walgreens#17617 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 175 Dean Street, Taunton, Massachusetts 02780 Phone: (508) 823-5270 |